Vanguard Capital Wealth Advisors trimmed its position in Nautilus Biotechnology, Inc. (NASDAQ:NAUT – Free Report) by 21.9% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 59,000 shares of the company’s stock after selling 16,500 shares during the quarter. Vanguard Capital Wealth Advisors’ holdings […]
Vir Biotechnology (NASDAQ:VIR – Get Free Report) released its earnings results on Thursday. The company reported ($1.45) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($1.21) by ($0.24), Briefing.com reports. The business had revenue of $3.80 million during the quarter, compared to analysts’ expectations of $22.39 million. The company’s quarterly revenue […]
Vir Biotechnology (VIR) Set to Announce Earnings on Thursday theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Vir Biotechnology (NASDAQ:VIR – Get Free Report) had its target price decreased by equities researchers at Barclays from $59.00 to $41.00 in a research report issued to clients and investors on Friday, FlyOnTheWall reports. Barclays‘s price target points to a potential upside of 222.83% from the company’s current price. A number of other equities research […]
Vir Biotechnology, Inc. (NASDAQ:VIR – Free Report) major shareholder Endurance (Cayman) Ltd Svf sold 700 shares of the company’s stock in a transaction that occurred on Friday, June 30th. The stock was sold at an average price of $25.11, for a total transaction of $17,577.00. Following the completion of the transaction, the insider now owns […]